Found: 110
Select item for more details and to access through your institution.
Splicing the way to leukemia with KIT.
- Published in:
- Leukemia & Lymphoma, 2008, v. 49, n. 8, p. 1431, doi. 10.1080/10428190802192759
- By:
- Publication type:
- Article
Uncovering the molecular mechanisms of amelanotic/hypopigmented primary cutaneous melanoma.
- Published in:
- British Journal of Dermatology, 2025, v. 192, n. 2, p. 55, doi. 10.1093/bjd/ljae336
- By:
- Publication type:
- Article
A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-37883-y
- By:
- Publication type:
- Article
Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. N.PAG, doi. 10.3389/fimmu.2021.661737
- By:
- Publication type:
- Article
Gene expression profiling of human colon xenograft tumors following treatment with SU11248, a multitargeted tyrosine kinase inhibitor.
- Published in:
- Oncogene, 2004, v. 23, n. 8, p. 1618, doi. 10.1038/sj.onc.1207268
- By:
- Publication type:
- Article
High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeninges.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 3, p. 423, doi. 10.1093/neuonc/noz171
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 2, p. 579, doi. 10.1245/s10434-015-4894-4
- By:
- Publication type:
- Article
Dermatofibrosarcoma Protuberans: Recent Clinical Progress.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2007, v. 14, n. 10, p. 2876, doi. 10.1245/s10434-007-9480-y
- By:
- Publication type:
- Article
Prospective comparison of volumetric post-contrast T1-Sampling Perfection with Application optimized Contrasts by using different flip angle Evolutions and Magnetization-Prepared Rapid Acquisition with Gradient Echo in patients with metastatic melanoma.
- Published in:
- Neuroradiology Journal, 2023, v. 36, n. 2, p. 169, doi. 10.1177/19714009221114440
- By:
- Publication type:
- Article
The Best Treatments to Use After Checkpoint Inhibition in Melanoma.
- Published in:
- Clinical Advances in Hematology & Oncology, 2017, v. 15, n. 4, p. 242
- By:
- Publication type:
- Article
Qualitative evaluation of a multidisciplinary master of cancer sciences: impacts on graduates and influencing curricular factors.
- Published in:
- BMC Medical Education, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12909-024-05744-0
- By:
- Publication type:
- Article
Designing a wholly online, multidisciplinary Master of Cancer Sciences degree.
- Published in:
- BMC Medical Education, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12909-023-04537-1
- By:
- Publication type:
- Article
Blending space and time to talk about cancer in extended reality.
- Published in:
- NPJ Digital Medicine, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s41746-024-01262-x
- By:
- Publication type:
- Article
Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series.
- Published in:
- Health Science Reports, 2019, v. 2, n. 3, p. N.PAG, doi. 10.1002/hsr2.115
- By:
- Publication type:
- Article
Towards new models of cancer care in Australia: lessons from Victoria's response to the COVID‐19 pandemic.
- Published in:
- Internal Medicine Journal, 2020, v. 50, n. 10, p. 1282, doi. 10.1111/imj.15012
- By:
- Publication type:
- Article
Acute toxic epidermal necrolysis reaction post single dose pembrolizumab with preceding cephalosporin exposure: successful rechallenge with anti‐PD‐1 therapy.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
Exploring the feasibility and utility of exome‐scale tumour sequencing in a clinical setting.
- Published in:
- Internal Medicine Journal, 2018, v. 48, n. 7, p. 786, doi. 10.1111/imj.13806
- By:
- Publication type:
- Article
Combination therapies to inhibit the RAF/MEK/ERK pathway in melanoma: we are not done yet.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00161
- By:
- Publication type:
- Article
Phenotype switching in melanoma: implications for progression and therapy.
- Published in:
- Frontiers in Oncology, 2015, v. 5, p. 1, doi. 10.3389/fonc.2015.00031
- By:
- Publication type:
- Article
c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation.
- Published in:
- Nucleic Acids Research, 2011, v. 39, n. 8, p. 3267, doi. 10.1093/nar/gkq1205
- By:
- Publication type:
- Article
The genomic landscape of phaeochromocytoma.
- Published in:
- Journal of Pathology, 2015, v. 236, n. 1, p. 78, doi. 10.1002/path.4503
- By:
- Publication type:
- Article
The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, p. 67, doi. 10.1007/s00259-017-3691-7
- By:
- Publication type:
- Article
Harnessing the immunotherapeutic potential of CDK4/6 inhibitors in melanoma: is timing everything?
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00273-9
- By:
- Publication type:
- Article
Changes in long-range rDNA-genomic interactions associate with altered RNA polymerase II gene programs during malignant transformation.
- Published in:
- Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0284-y
- By:
- Publication type:
- Article
UBF levels determine the number of active ribosomal RNA genes in mammals.
- Published in:
- Journal of Cell Biology, 2008, v. 183, n. 7, p. 1259, doi. 10.1083/jcb.200805146
- By:
- Publication type:
- Article
Genome-wide RNAi screen for genes regulating glycolytic response to vemurafenib in BRAF<sup>V600</sup> melanoma cells.
- Published in:
- Scientific Data, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1038/s41597-020-00683-z
- By:
- Publication type:
- Article
Enhancing Adoptive Cell Transfer with Combination BRAF-MEK and CDK4/6 Inhibitors in Melanoma.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6342, doi. 10.3390/cancers13246342
- By:
- Publication type:
- Article
Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies.
- Published in:
- Cancers, 2021, v. 13, n. 22, p. 5810, doi. 10.3390/cancers13225810
- By:
- Publication type:
- Article
PRMT5: An Emerging Target for Pancreatic Adenocarcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5136, doi. 10.3390/cancers13205136
- By:
- Publication type:
- Article
CDK4/6 Inhibition Reprograms Mitochondrial Metabolism in BRAF V600 Melanoma via a p53 Dependent Pathway.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 524, doi. 10.3390/cancers13030524
- By:
- Publication type:
- Article
Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1583, doi. 10.3390/cancers12061583
- By:
- Publication type:
- Article
Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation.
- Published in:
- EMBO Journal, 1998, v. 17, n. 3, p. 774, doi. 10.1093/emboj/17.3.774
- By:
- Publication type:
- Article
Ubiquitous expression of the Pik3ca<sup>H1047R</sup> mutation promotes hypoglycemia, hypoinsulinemia, and organomegaly.
- Published in:
- FASEB Journal, 2015, v. 29, n. 4, p. 1426, doi. 10.1096/fj.14-262782
- By:
- Publication type:
- Article
coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF<sup>V600</sup> mutation-positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519).
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Novel combination therapies for BRAF-mutant melanoma.
- Published in:
- Journal of Translational Medicine, 2015, v. 13, p. 1, doi. 10.1186/1479-5876-13-S1-K6
- By:
- Publication type:
- Article
AKT signalling is required for ribosomal RNA synthesis and progression of Eμ- Myc B-cell lymphoma in vivo.
- Published in:
- FEBS Journal, 2013, v. 280, n. 21, p. 5307, doi. 10.1111/febs.12135
- By:
- Publication type:
- Article
Lymphatic and Hematogenous Dissemination in Patients With Primary Cutaneous Melanoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The therapeutic potential of targeting minimal residual disease in melanoma.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 3, p. 1, doi. 10.1002/ctm2.1197
- By:
- Publication type:
- Article
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 8, p. 2176, doi. 10.1002/ijc.33000
- By:
- Publication type:
- Article
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
- Published in:
- International Journal of Cancer, 2018, v. 142, n. 10, p. 2139, doi. 10.1002/ijc.31220
- By:
- Publication type:
- Article
Bioinformatics Pipelines for Targeted Resequencing and Whole-Exome Sequencing of Human and Mouse Genomes: A Virtual Appliance Approach for Instant Deployment.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095217
- By:
- Publication type:
- Article
CDC25B Overexpression Stabilises Centrin 2 and Promotes the Formation of Excess Centriolar Foci.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0067822
- By:
- Publication type:
- Article
Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer.
- Published in:
- PLoS ONE, 2008, v. 3, n. 8, p. 1, doi. 10.1371/journal.pone.0002987
- By:
- Publication type:
- Article
BRAF, a Target in Melanoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 21, p. 4902, doi. 10.1002/cncr.25261
- By:
- Publication type:
- Article
Prospective Comparison of T1-SPACE and MPRAGE for the Identification of Intrinsic T1 Hyperintensity in Patients with Intracranial Melanoma Metastases.
- Published in:
- American Journal of Neuroradiology, 2023, v. 44, n. 9, p. 1039, doi. 10.3174/ajnr.A7975
- By:
- Publication type:
- Article
MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation.
- Published in:
- EMBO Journal, 2004, v. 23, n. 16, p. 3325, doi. 10.1038/sj.emboj.7600335
- By:
- Publication type:
- Article
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 3, p. 1371, doi. 10.1172/JCI66236
- By:
- Publication type:
- Article
An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 2, p. 553, doi. 10.1172/JCI59309
- By:
- Publication type:
- Article